Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

International Society for Prenatal Diagnosis Position Statement: cell free (cf) DNA screening for Down syndrome in multiple pregnancies

5 Oct 2020

Abstract excerpt

The aim of this Position Statement from the International Society for Prenatal Diagnosis (ISPD) is to review the relevant published literature and make evidence-based recommendations regarding screening twin and triplet pregnancies for Down syndrome via cell free (cf)DNA testing. This Position Statement should not be taken to be an endorsement that cfDNA is the optimal choice for all women with multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Congenital Anomalies and Fetal Surgery
Share to Parvovirus B19 Infection Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33016373
DOI: 10.1002/pd.5832

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

International Society for Prenatal Diagnosis Position Statement: cell free (cf) DNA screening for Down syndrome in multiple pregnanciesPMID 33016373Read ↗

Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screeningSemantic proximity Read ↗

Current controversies in prenatal diagnosis 2: Cell‐free DNA prenatal screening should be used to identify all chromosome abnormalitiesSemantic proximity Read ↗

The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosisSemantic proximity Read ↗

Cell-free DNA: Comparison of Technologies.Semantic proximity Read ↗

Advances in Prenatal Cell‐Free DNA Screening for Dominant Monogenic Conditions: A Review of Current Progress and Future Directions in Clinical ImplementationSemantic proximity Read ↗

Noninvasive prenatal testing for aneuploidy using cell-free DNA – New implications for maternal healthSemantic proximity Read ↗

Has Noninvasive Prenatal Testing Impacted Termination of Pregnancy and Live Birth Rates of Infants With Down Syndrome?Semantic proximity Read ↗

Noninvasive Prenatal Diagnosis of Single-Gene Diseases: The Next FrontierSemantic proximity Read ↗

ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practiceSemantic proximity Read ↗

Cell-Free DNA Testing for Fetal Chromosomal Anomalies in clinical practice: Austrian-German-Swiss Recommendations for non-invasive prenatal tests (NIPT)Semantic proximity Read ↗

Cell‐free <scp>DNA</scp> testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10–14 weeks and meta‐analysisSemantic proximity Read ↗

Initial experience with non-invasive prenatal testing of cell-free DNA for major chromosomal anomalies in a clinical settingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.